IL17A Antibodies and Antagonists for Veterinary Use

作者: Nguyen Lam , Li Shyr Jiann , Zhan Hangjun , Yang Lan

DOI:

关键词:

摘要: Provided are various embodiments relating to anti-IL17A antibodies and IL17Ra ECD polypeptides that bind IL17A. In embodiments, such or can be used in methods treat IL17-induced conditions subjects, as humans companion animals, canines, felines, equines. Also provided IgG Fc variant having one more amino acid substitutions for reducing binding C1q and/or CD16. some the variants comprising (e.g., fusion described herein) may have reduced complement-mediated immune responses antibody-dependent cell-mediated cytotoxicity.

参考文章(6)
Marianna Zaretzky, Amir Aharoni, Novel il-17r-ecd mutants ,(2012)
Monika Baehner, Tilman Schlothauer, Manfred Kubbies, Stefan Jenewein, Ekkehard Moessner, Antibody fc variants ,(2012)
Kutlu Goksu Elpek, Sriram Sathyanarayanan, Stephen Sazinsky, Jennifer S. Michaelson, Antibodies to ICOS ,(2016)
Jane Grogan, Patrick Caplazi, Jason Hackney, Steve Lianoglou, Eugene Yu-Chuan Chiang, Yuanyuan Xiao, Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists ,(2015)
He Zhonghuai, Jin Jin, Xie Xiaoping, Wang Bin, Yu Qingling, VACCINES WITH INTERLEUKIN-17 AS AN ADJUVANT ,(2017)